Shares in Vetoquinol Sa (EPA:VETO) are currently trading at 92 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price in the months to come. The answer comes down to judging whether Ve...
|Type||Buy / Hold / Sell|
|Year End 31st Dec||Unit||2016||2017||2018||2019||2020||2021E||2022E||CAGR / Avg|
|Diluted Normalised EPS|
|Op. Cashflow ps|
|Free Cashflow ps|
|Diluted Weighted Average Shares||m|
|Book Value ps|
|Leverage (ttm)||Total||- Intang||+ Pension|
|Cash / Assets|
Latest News & Insights for VETO
Shares in Vetoquinol Sa (EPA:VETO) are currently trading at 89.6 but a key question for investors is how much the economic chaos of 2020 will impact on the price. Part of the answer could come down to whether it is well placed to ride...
Shares in Vetoquinol Sa (EPA:VETO) are currently trading at 69.6 but the question for investors is how much the economic chaos of 2020 will impact on its price. Part of the answer could come come down to whether it is well placed to ri...
The Vetoquinol Sa (EPA:VETO) share price is currently trading at 73. But to try and predict what the price will look like in the next 12 months and beyond, it's worth knowing its strengths and potential weaknesses. The good news for sh...
Covid-19 has shaken world markets. One question likely to be on the minds of a lot of investors right now is how economic uncertainty caused by the pandemic will continue to affect mid-cap shares, such as the share price of Vetoquinol...
Vetoquinol SA is a France-based company that specializes in the research, development, manufacture, marketing and sale of veterinary drugs and products. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The Company markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. It trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
- Etienne Frechin CHM (75)
- Matthieu Frechin CEO (44)
- Alain Masson DCE (51)
- Regis Vimal du Monteil CFO (47)
- Hans Hollegien DMK
- Isabelle Proust-Cabrera DHR
- Alain Chaptal EXB
- Dominique Derveaux EXB
- Thomas Robitaille EXB
- Dan Tasli EXB
- Marie-Josephe Baud DRC
- Francois Frechin DRC (80)
- Jean-Charles Frechin DRC (68)
- Martine Frechin DRC (74)
- Philippe Arnold IND (72)
- Louis Champel IND (69)
Latest News for VETO
Upcoming Events for VETO
Q4 2021 Vetoquinol SA Corporate Sales Release
As of Today at 18:47 UTC, shares in Vetoquinol SA are trading at €132.00. This share price information is delayed by 15 minutes.
Shares in Vetoquinol SA last closed at €132.00 and the price had moved by +62.16% over the past 365 days. In terms of relative price strength the Vetoquinol SA share price has outperformed the FTSE Global All Cap Index by +35.65% over the past year.
The overall consensus recommendation for Vetoquinol SA is Buy. You can view the full broker recommendation list by unlocking its StockReport.
The Vetoquinol SA dividend yield is 0.38% based on the trailing twelve month period.
Last year, Vetoquinol SA paid a total dividend of €0.50, and it currently has a trailing dividend yield of 0.38%. We do not have any data on when Vetoquinol SA is to next pay dividends.
We do not have data on when Vetoquinol SA is to next pay dividends. The historic dividend yield on Vetoquinol SA shares is currently 0.38%.
To buy shares in Vetoquinol SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €132.00, shares in Vetoquinol SA had a market capitalisation of €1.56bn.
Here are the trading details for Vetoquinol SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: VETO
Based on an overall assessment of its quality, value and momentum Vetoquinol SA is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Vetoquinol SA is €140.93. That is 6.77% above the last closing price of €132.00.
Analysts covering Vetoquinol SA currently have a consensus Earnings Per Share (EPS) forecast of €5.13 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vetoquinol SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +17.68%.
As of the last closing price of €132.00, shares in Vetoquinol SA were trading +11.94% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Vetoquinol SA PE ratio based on its reported earnings over the past 12 months is 24.98. The shares last closed at €132.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Vetoquinol SA's management team is headed by:
- Etienne Frechin - CHM
- Matthieu Frechin - CEO
- Alain Masson - DCE
- Regis Vimal du Monteil - CFO
- Hans Hollegien - DMK
- Isabelle Proust-Cabrera - DHR
- Alain Chaptal - EXB
- Dominique Derveaux - EXB
- Thomas Robitaille - EXB
- Dan Tasli - EXB
- Marie-Josephe Baud - DRC
- Francois Frechin - DRC
- Jean-Charles Frechin - DRC
- Martine Frechin - DRC
- Philippe Arnold - IND
- Louis Champel - IND